Literature DB >> 20080916

Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.

Sara E Löfgren1, Hong Yin, Angelica M Delgado-Vega, Elena Sanchez, Susanna Lewén, Bernardo A Pons-Estel, Torsten Witte, Sandra D'Alfonso, Norberto Ortego-Centeno, Javier Martin, Marta E Alarcón-Riquelme, Sergey V Kozyrev.   

Abstract

OBJECTIVE: We examined the genetic association of the promoter insertion/deletion (indel) in IRF5 gene with systemic lupus erythematosus (SLE) in distinct populations and assessed its role in gene expression.
METHODS: Four IRF5 polymorphisms were genotyped in 1488 SLE patients and 1466 controls. Gene expression was analyzed by quantitative real-time PCR using RNA from peripheral blood mononuclear cells (PBMC).
RESULTS: The promoter indel and rs2070197 had independent genetic effects, which accounted for the association of rs2004640 and rs10954213. Gene expression analysis revealed that rs10954213 exerted the greatest influence on IRF5 transcript levels.
CONCLUSION: We corroborated the association of the promoter indel with SLE in 5 different populations and revealed that rs10954213 is the main single-nucleotide polymorphism responsible for altered IRF5 expression in PBMC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080916     DOI: 10.3899/jrheum.090440

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  20 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

2.  IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.

Authors:  Dan Li; Bharati Matta; Su Song; Victoria Nelson; Kirsten Diggins; Kim R Simpfendorfer; Peter K Gregersen; Peter Linsley; Betsy J Barnes
Journal:  JCI Insight       Date:  2020-01-30

3.  Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.

Authors:  Liang Tang; Pengcheng Wan; Yong Wang; Jiabao Pan; Yan Wang; Bifeng Chen
Journal:  Inflamm Res       Date:  2015-08-21       Impact factor: 4.575

Review 4.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 5.  Genetic susceptibility to systemic lupus erythematosus in the genomic era.

Authors:  Yun Deng; Betty P Tsao
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

Review 6.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

Review 7.  Advances in lupus genetics and epigenetics.

Authors:  Yun Deng; Betty P Tsao
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

8.  Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis.

Authors:  Hui-Feng Liu; Xiang-Jie An; Yan Yang; Liu Yang; Yan Li; Chang-Zheng Huang; Juan Tao; Ya-Ting Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

Review 9.  Association of the IRF5 rs2070197 polymorphism with systemic lupus erythematosus: a meta-analysis.

Authors:  Yuan Li; Si Chen; Ping Li; Ziyan Wu; Jing Li; Bin Liu; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2015-08-02       Impact factor: 2.980

Review 10.  Genetic Versus Non-genetic Drivers of SLE: Implications of IRF5 Dysregulation in Both Roads Leading to SLE.

Authors:  Betsy J Barnes
Journal:  Curr Rheumatol Rep       Date:  2019-01-15       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.